Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
(→ATC) |
(→ATC) |
||
| Line 17: | Line 17: | ||
[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy] | [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307870/pdf/main.pdf Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy] | ||
==[[ATC]]== | ==[[ATC code N03|ATC]]== | ||
<gallery>File:Topiramate_3D.png</gallery> | <gallery>File:Topiramate_3D.png</gallery> | ||
Latest revision as of 15:13, 25 October 2024
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Phentermine and topiramate for the management of obesity: a review
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy
ATC
| References: |